SHWGY OTC
Shandong Weigao Group Medical Polymer Company Limited
1W: -11.6%
1M: -3.3%
3M: -9.4%
YTD: -45.7%
1Y: -50.3%
3Y: -55.2%
5Y: -75.8%
$1.45
+0.00 (+0.00%)
Overview
Chart
Smart Money
Financials
Income Statement
Cash Flow
Balance Sheet
Earnings
Analysis
Technicals
Weather
Peers
ESG
Institutions
Dark Pool
Short Interest
Balance Sheet Trends
Total Assets
$36.1B
+3.8% ▲
5Y CAGR: +5.7%
Total Liabilities
$10.2B
+8.7% ▲
5Y CAGR: +2.7%
Shareholders Equity
$24.1B
+1.6% ▲
5Y CAGR: +6.6%
Cash & Investments
$9.9B
+18.6% ▲
5Y CAGR: +10.0%
Total Debt
$6.0B
+42.8% ▲
5Y CAGR: +6.7%
Net Debt
-$3.0B
+16.4% ▲
Assets vs Liabilities & Equity
Year-over-Year Growth
View Full Balance Sheet
| Line Item | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|
| — Assets — | |||||
| Cash | $6.6B | $6.9B | $7.0B | $7.8B | $9.0B |
| Short-Term Investments | $430M | $522M | $345M | $541M | $884M |
| Cash & ST Investments | $7.1B | $7.5B | $7.3B | $8.3B | $9.9B |
| Net Receivables | $5.2B | $5.7B | $7.3B | $7.5B | $8.3B |
| Inventory | $1.8B | $2.3B | $2.5B | $2.5B | $2.5B |
| Other Current Assets | $1.7B | $2.9B | $798M | $446M | $7 |
| Total Current Assets | $16.3B | $18.3B | $18.6B | $19.4B | $20.7B |
| Property, Plant & Equip. | $6.7B | $7.3B | $7.0B | $7.3B | $7.5B |
| Goodwill & Intangibles | $5.1B | $5.4B | $5.1B | $5.1B | $4.7B |
| Long-Term Investments | $991M | $1.4B | $1.9B | $1.4B | $2.8B |
| Other Non-Current Assets | $1.3B | $914M | $1.1B | $1.1B | $45M |
| Total Non-Current Assets | $14.3B | $15.1B | $15.0B | $15.3B | $15.4B |
| Total Assets | $30.4B | $33.2B | $33.7B | $34.8B | $36.1B |
| — Liabilities — | |||||
| Accounts Payable | $1.7B | $1.8B | $4.3B | $4.3B | $1.2B |
| Short-Term Debt | $601M | $961M | $2.5B | $1.2B | $1.4B |
| Deferred Revenue | $2.7B | $0 | $0 | $0 | $333M |
| Other Current Liabilities | -$2.4B | $335M | $449M | $366M | $2.4B |
| Total Current Liabilities | $5.2B | $5.9B | $7.6B | $6.1B | $5.5B |
| Long-Term Debt | $3.5B | $3.4B | $1.5B | $2.8B | $4.4B |
| Other Non-Current Liab. | $523M | $37M | $264M | $232M | $27M |
| Total Non-Current Liabilities | $4.3B | $3.8B | $2.1B | $3.3B | $4.8B |
| Total Liabilities | $9.5B | $9.7B | $9.7B | $9.4B | $10.2B |
| — Equity — | |||||
| Common Stock | $457M | $457M | $457M | $457M | $457M |
| Retained Earnings | $15.4B | $17.6B | $18.6B | $19.9B | $0 |
| Accumulated OCI | $763M | $982M | $0 | $0 | $0 |
| Total Stockholders Equity | $19.3B | $21.7B | $22.4B | $23.8B | $24.1B |
| Total Liabilities & Equity | $30.4B | $33.2B | $33.7B | $34.8B | $36.1B |
| — Key Metrics — | |||||
| Total Debt | $4.1B | $4.5B | $4.2B | $4.2B | $6.0B |
| Net Debt | -$2.5B | -$2.4B | -$2.8B | -$3.6B | -$3.0B |
| Total Investments | $1.4B | $1.9B | $2.2B | $2.0B | $3.7B |